Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
2.000
+0.040 (2.04%)
At close: May 22, 2026, 4:00 PM EDT
1.990
-0.010 (-0.50%)
After-hours: May 22, 2026, 7:49 PM EDT
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $690.31 million as of May 22, 2026. Its market cap has increased by 167.49% in one year.
Market Cap
690.31M
Enterprise Value
504.47M
1-Year Change
167.49%
Ranking
Category
Stock Price
$2.00
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $690.31M, a decrease of -76.04%. That is a compound annual growth rate of -17.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 690.31M | 124.21% |
| Dec 31, 2025 | 307.88M | -31.06% |
| Dec 31, 2024 | 446.60M | -17.32% |
| Dec 29, 2023 | 540.17M | -40.45% |
| Dec 30, 2022 | 907.08M | -57.34% |
| Dec 31, 2021 | 2.13B | -39.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 755.04M |
| SpyGlass Pharma | 737.06M |
| BridgeBio Oncology Therapeutics | 729.10M |
| Tenax Therapeutics | 727.74M |
| Design Therapeutics | 687.65M |
| Crescent Biopharma | 672.22M |
| Solid Biosciences | 639.92M |
| Aclaris Therapeutics | 634.07M |